Literature DB >> 16006214

Prevalence of hepatitis B virus (HBV) infection among Makerere University medical students.

Bongomin Pido1, Magid Kagimu.   

Abstract

BACKGROUND: Medical students in the course of their clinical work are at risk of acquiring hepatitis B virus (HBV) infection or transmitting it to their patients. HBV immunization for medical students in Uganda is recommended but not strictly enforced. It is important to assess the prevalence of HBV infection in medical students in order to improve on the interventions to control this infection among them.
OBJECTIVES: The objective of the study was to assess the seroprevalence rates of HBsAg and anti-HBc among clinical and preclinical medical students.
METHODS: This was a cross-sectional study done over three months from November 2000 to January 2001 among Makerere University Medical students. A random sample of medical students was recruited from both the pre-clinical and clinical years. Blood samples from each participant were tested for HBsAg and anti-HBc.
RESULTS: The overall prevalence was 11.0% for HBsAg and 65.9% for anti HBc. Nine pre-clinical students (12.2%) were positive for HBsAg compared to 11 (10.2%) clinical students. This difference was not statistically significant. However, clinical students were more likely to have been exposed to HBV with 86 (79.6%) testing positive for anti-HBc compared to 34 (45.9%) among preclinical students (p-value <001). Risk factors associated HBV infection included having a sexual relationship, accidental needlestick injuries, and unprotected exposure to patients' body fluids.
CONCLUSION: Medical students need to be offered more sensitization and support regarding prevention of HBV infection including vaccination and the use of universal precautions for infection control.

Entities:  

Mesh:

Year:  2005        PMID: 16006214      PMCID: PMC1831914     

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  7 in total

1.  Planning and execution of a successful hepatitis B immunization program.

Authors:  J L Hurley; H S Turner; K M Butler
Journal:  J Am Coll Health       Date:  2001-01

2.  Differences in hepatitis B markers between clinical and preclinical health care personnel.

Authors:  V Khurana; P Kar; N Mansharamani; V Jain; A Kanodia
Journal:  Trop Gastroenterol       Date:  1997 Apr-Jun

3.  What is the clinical impact of occult hepatitis B virus infection?

Authors:  Giovanni Raimondo; Teresa Pollicino; Giovanni Squadrito
Journal:  Lancet       Date:  2005 Feb 19-25       Impact factor: 79.321

4.  Prevalence and epidemiological characteristics of hepatitis B and C infections among doctors and dentists in Nigeria.

Authors:  I O Olubuyide; S O Ola; B Aliyu; O O Dosumu; J T Arotiba; O A Olaleye; G N Odaibo; S O Odemuyiwa; F Olawuyi
Journal:  East Afr Med J       Date:  1997-06

5.  HBV markers (HBsAg, HBSAb, HBCAb in 160 medical students at Kenyatta National Hospital.

Authors:  G N Lule; F Okoth; E O Ogutu; S J Mwai
Journal:  East Afr Med J       Date:  1989-05

Review 6.  Blood-borne virus infection: the occupational risks.

Authors:  L A Riddell; J Sherrard
Journal:  Int J STD AIDS       Date:  2000-10       Impact factor: 1.359

7.  Vaccination against hepatitis B in health care workers.

Authors:  P Bonanni; G Bonaccorsi
Journal:  Vaccine       Date:  2001-03-21       Impact factor: 3.641

  7 in total
  13 in total

1.  Hepatitis B virus seroprevalence among Malawian medical students: A cross-sectional study.

Authors:  Froid Chipetah; Aaron Chirambo; Ednas Billiat; Isaac Thom Shawa
Journal:  Malawi Med J       Date:  2017-03       Impact factor: 0.875

Review 2.  Hepatitis B virus burden in developing countries.

Authors:  Rosa Zampino; Adriana Boemio; Caterina Sagnelli; Loredana Alessio; Luigi Elio Adinolfi; Evangelista Sagnelli; Nicola Coppola
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

3.  Hepatitis B infection is highly endemic in Uganda: findings from a national serosurvey.

Authors:  Josephine Bwogi; Fiona Braka; Issa Makumbi; Vinod Mishra; Barnabas Bakamutumaho; Miriam Nanyunja; Alex Opio; Robert Downing; Benon Biryahwaho; Rosamund F Lewis
Journal:  Afr Health Sci       Date:  2009-06       Impact factor: 0.927

4.  Knowledge, attitudes, and practice of medical students regarding occupational risks of hepatitis B virus in college of medicine, aljouf university.

Authors:  Ah Al-Hazmi
Journal:  Ann Med Health Sci Res       Date:  2015 Jan-Feb

5.  Senior health sciences students' perception of occupational risk of viral hepatitis and attitudes toward patients diagnosed with viral hepatitis B and C.

Authors:  Raed Almutairi; Muneer Almutairi; Ali Alsugair; Moayad Alseraikh; Huda Almutairi
Journal:  Int J Health Sci (Qassim)       Date:  2017 Sep-Oct

6.  Low Coverage of Hepatitis B Vaccine and Determinants Among Health Professionals Working in Amhara Regional State Hospitals, Ethiopia.

Authors:  Berhanu Elfu Feleke
Journal:  J Public Health Afr       Date:  2016-12-31

7.  Hepatitis B vaccination status and associated factors among undergraduate students of Makerere University College of Health Sciences.

Authors:  Yvette Wibabara; Cecily Banura; Joan Kalyango; Charles Karamagi; Alex Kityamuwesi; Winfred Christine Amia; Ponsiano Ocama
Journal:  PLoS One       Date:  2019-04-05       Impact factor: 3.240

8.  Trends in the incidence of primary liver cancer in Central Uganda, 1960-1980 and 1991-2005.

Authors:  P Ocama; S Nambooze; C K Opio; M S Shiels; H R Wabinga; G D Kirk
Journal:  Br J Cancer       Date:  2009-01-27       Impact factor: 7.640

9.  Hepatitis B and C: Seroprevalence, knowledge, practice and associated factors among medicine and health science students in Northeast Ethiopia.

Authors:  Wondmagegn Demsiss; Abdurahaman Seid; Temesgen Fiseha
Journal:  PLoS One       Date:  2018-05-15       Impact factor: 3.240

10.  Correlates of hepatitis B awareness and disease-specific knowledge among pregnant women in Northern and Central Uganda: a cross-sectional study.

Authors:  Joan Nankya-Mutyoba; Jim Aizire; Fredrick Makumbi; Lynn Atuyambe; Ponsiano Ocama; Gregory D Kirk
Journal:  Hepatol Med Policy       Date:  2018-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.